HOME >> BIOLOGY >> NEWS
Top experts and scientists at BioFinland 05 Congress

The congress with its theme Genomic Drug Discovery will approach the entire drug discovery chain from bench to bedside. Identification of targets, validation, and clinical trials are dramatically changing as a consequence of powerful genomics tools being applied in all these areas.

The congress speakers come both from the industry and academia, and they are among others Nobel Laureate (1993) Richard J. Roberts (USA), Leif Groop (Sweden), David R. Cox (USA), Peter Shaw (USA), Kari Alitalo (Finland), Robert G. Pietrusko (USA) and Ruth March (UK).

BioFinland 05 will be held at the Helsinki Fair Centre, April 26 - 27, 2005. The organizers of the congress are Finnish Bioindustries, SITRA (the Finnish National Fund for Research and Development) and Tekes (the Finnish National Technology Agency) as well as the Finnish Fair Corporation.

At the same time, an Investor Forum will be arranged for investors and companies in the bioindustry. Furthermore, there will be ChemBio Finland 05 Exhibition , which will highlight latest innovations and developments within chemical and biotechnology as well as laboratory analytics.

Reduced registration fee until February 28.

For more information on the BioFinland 05 Congress and the speakers: www.biofinland.fi


'"/>

Contact: Ms Saara Hassinen, Assistant Director, Finnish Bioindustries
saara.hassinen@finbio.net
358-917-284-308
Consulate General of Finland
21-Feb-2005


Page: 1

Related biology news :

1. UC experts detail new standard for cleaner transportation fuels
2. Desertification: UN experts prescribe global policy overhaul to avoid looming mass migrations
3. Human ancestors learned to walk upright in the trees, say experts
4. Antarctic lake experts to gather June 6, 7 in Montana
5. Renowned nutrition experts tackle nations obesity problem in new book on primary care nutrition
6. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
7. ALTRAN: Industry experts address technology challenges at Altran Innovation Conference
8. Detaining patients is justified to contain deadly TB strain in South Africa say experts
9. Genetic experts investigate causes of harmful metabolic disorder
10. Specter of possible harm threatens nanotech development, experts say
11. UF experts: Decaffeinated coffee is not caffeine-free

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Top experts and scientists BioFinland Congress

(Date:6/18/2013)... Faculty of Medicine have discovered a mechanism that is ... a component of blood typically associated with clotting, were ... detection, seal it off from the rest of the ... Immunology this week, provide the science community with ... has known that platelets do participate in immunity, but ...
(Date:6/18/2013)... United Kingdom, the Energy Department,s National Renewable Energy ... recently published a paper describing a novel cellulose-degrading ... quadripunctata , commonly known as the gribble. ... a relatively unique ability to produce their own ... down the biomass they eat. New biomass-degrading enzymes ...
(Date:6/18/2013)... A UT Arlington environmental engineer has been awarded ... District to ensure water quality and flow in ... Project. , Andrew Kruzic, UT Arlington associate professor ... and locations to add monochloramine to the water ... the new pump stations and pipelines. Adding monochloramine ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2Novel enzyme from tiny gribble could prove a boon for biofuels research 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
(Date:6/18/2013)... June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has received approval ... (DEA) registration to handle Schedule 2 and 2N ... of Burlington,s physical security ... (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... ZIONA, Israel , June 18, 2013 /PRNewswire/ ... bulk Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and ... today that the company has been granted a ... in the US and Europe for ... Patent number 8,410,176 B2 is titled Intermediate Compounds and ...
(Date:6/18/2013)... This webinar will examine the history ... and review the basic FDA regulations and guiding ... these principles through real world case studies and ... on FDA regulations and guidance related to prescription ... traditional and newer forms of promotional materials for ...
(Date:6/18/2013)... , June 18, 2013 ... ) has announced the addition of the ... [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & ... & Auto Injectors] & Therapeutics [Diabetes & ... report to their offering.      ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
Cached News: